Stroke remains a leading cause of mortality and disability worldwide. Early recognition and prompt management are crucial to improving outcomes. This brief review aims to provide an overview of the essential strategies for early stroke recognition and management in clinical practice.
The acronym FAST (Face, Arms, Speech, Time) is a vital tool for early stroke recognition. It highlights the importance of quick response to the sudden onset of facial drooping, arm weakness, and speech difficulties. Time is a critical factor, reminding healthcare professionals that every minute counts when it comes to stroke treatment.
The first 60 minutes following a stroke, often referred to as the 'Golden Hour,' are critical for patient prognosis. Immediate management includes stabilizing vital signs, performing a neurological evaluation, and initiating reperfusion therapy, if indicated. Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) remains the standard of care for eligible patients.
Secondary prevention strategies are vital to reducing stroke recurrence. These include managing hypertension, diabetes, and dyslipidemia, promoting a healthy lifestyle, and initiating antithrombotic therapy. Patient education is also crucial, emphasizing the importance of medication adherence and regular follow-up.
Early recognition and prompt management of stroke can significantly improve patient outcomes. The FAST acronym is a practical tool for early recognition, while immediate management and secondary prevention strategies are key to reducing mortality and disability. As healthcare professionals, we must remain vigilant and proactive in our approach to this devastating condition.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation